Pharmaceutical / Drug Definition :
Inhibits calcium ion movement across cell membranes of cardiac and arterial muscles, relaxing coronary and peripheral vascular smooth muscle. This action reduces diastolic blood pressure, enhances left ventricular function, and improves ejection rates; it also reduces mean vascular and systemic vascular resistance, increasing cardiac output and improving stroke volume.
In the United States, Isradipine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Isradipine.
Registrar Corp assists Isradipine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Isradipine (Isradipine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Isradipine (Isradipine Suppliers)
- Processors Isradipine
- Repackers Isradipine
- Relabelers Isradipine
- Exporters Isradipine
- Importers Isradipine
For more information about Isradipine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.